Info@ThinkPinkRocks.org

Dana-Farber Cancer Institute (Dana-Farber) and Astellas Pharma Inc. today announced a three-year collaboration to research and develop small molecule inhibitors of oncogenic K-Ras for the treatment of cancer, including lung cancer.

Continue reading here:
Astellas, Dana-Farber to develop K-Ras inhibitors for treatment of lung, pancreatic cancers

Scroll to Top